About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Study of Phosphate Levels in Patients With Chronic Kidney Disease

Study of Phosphate Levels in Patients With Chronic Kidney Disease

NCT00824460·60 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Vifor Pharma

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

≥ 18 years of age,
Receiving stable maintenance hemodialysis 3 times a week
On restricted phosphate diet at screening and throughout study
Receiving stable dose of phosphate binder for at least 1 month
Serum phosphate levels \>1.78 mmol/L

You may not be if

Uncontrolled hyperphosphatemia
Hypercalcemia at screening or during washout
Serum calcium \< 1.9 mmol/L (\<7.6 mg/dL)
Severe hyperparathyroidism (iPTH levels \>600 ng/L)
Pregnancy or lactation
Iron deficiency anemia
History of hemochromatosis or ferritin \>800 mg/L,
Hepatitis B, hepatitis C or other significant concurrent liver disorders
Known positivity to HIV
Use of oral iron preparations 1 month before screening,
Serious medical condition or uncontrolled systemic disease

The record

StatusCompleted

PhasePhase 2

Taking part154

StartedDec 2008

UpdatedApr 1, 2014

Conditions

Chronic Kidney Disease

Where60

Western Nephrology & Metabolic Disease
Arvada, Colorado, United States
Complete Renal Care
Denver, Colorado, United States
Pines Clinical Research
Pembroke Pines, Florida, United States